Американское общество гирудотерапии

Management of complications and compromised free flaps following major head and neck surgery

Retrospective cohort published in Eur Arch Otorhinolaryngol (2015)

Последнее обновление: June 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportКлинические исследованияБезопасность и инфекционный контрольKucur C et al. · European archives of oto-rhino-laryngology, 2015

Abstract

Microvascular free flaps are preferred for most major head and neck reconstruction surgeries because of better functional outcomes, improved esthetics, and generally higher success rates. Numerous studies have investigated measures to prevent flap loss, but few have evaluated the optimal treatment for free flap complications. This study aimed to determine the complication rate after free flap reconstructions and discusses our management strategies. Medical records of 260 consecutive patients who underwent free flap reconstructions for head and neck defects between July 2006 and June 2010 were retrospectively reviewed for patient and surgical characteristics and postoperative complications. The results revealed that microvascular free flaps were extremely reliable, with a 3.5 % incidence of flap failure. There were 78 surgical site complications. The most common complication was neck wound infection, followed by dehiscence, vascular congestion, abscess, flap necrosis, hematoma, osteoradionecrosis, and brisk bleeding. Twenty patients with poor wound healing received hyperbaric oxygen therapy, which was ineffective in three patients who eventually experienced complete flap loss. Eleven patients with vascular congestion underwent medicinal leech therapy, which was effective. Among the 78 patients with complications, 44 required repeat surgery, which was performed for postoperative brisk bleeding in three. Eventually, ten patients experienced partial flap loss and nine experienced complete flap loss, with the latter requiring subsequent pectoralis major flap reconstruction. Microvascular free flap reconstruction represents an essential and reliable technique for head and neck defects and allows surgeons to perform radical resection with satisfactory functional results and acceptable complication rates.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsFemaleFree Tissue FlapsHead and Neck NeoplasmsHematomaHumansHyperbaric OxygenationMaleMiddle AgedNeck DissectionOhioOsteoradionecrosisPostoperative Complications

Резюме

260-patient retrospective at Ohio State 2006-2010: 3.5% flap failure rate; 11 patients with vascular congestion received medicinal leech therapy with effective resolution.

Почему это важно для гирудотерапии

This study retrospectively reviewed medical records of 260 consecutive patients who underwent free flap reconstruction for head and neck defects between July 2006 and June 2010, reporting a 3.5% incidence of flap failure and 78 surgical site complications. The abstract states that, among management strategies, eleven patients with vascular congestion were treated with medicinal leech therapy, which was effective. For ASH's domain, this provides a clinical report of leech therapy used for vascular congestion in compromised head and neck free flaps. However, no details are given regarding leech species, protocol, duration, complications, or comparative effectiveness, and leech therapy is a secondary element within a broader surgical-complication management study.

Цитирование

Management of complications and compromised free flaps following major head and neck surgery.

Kucur C et al. · European archives of oto-rhino-laryngology, 2015

Связанный клинический контекст

Узнайте, как это исследование связано с клинической практикой

Добавлено в библиотеку ASH: May 27, 2026 · Последнее обновление сайта: June 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.